- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tibet Pharmaceuticals Inc (TBET)
Tibet Pharmaceuticals Inc stock price live, this page displays OTC TBET stock exchange data. View the TBET premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tibet Pharmaceuticals Inc real time stock price chart below.
What Is the Tibet Pharmaceuticals Inc Stock Price Today?
The Tibet Pharmaceuticals Inc stock price today is 0.00000.
What Is the Stock Symbol for Tibet Pharmaceuticals Inc?
The stock symbol for Tibet Pharmaceuticals Inc is ""TBET.""
What Stock Exchange Does Tibet Pharmaceuticals Inc Trade On?
Tibet Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Tibet Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Tibet Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TBET quote. (ISIN: VGG886151023)
What Is the Tibet Pharmaceuticals Inc Stock Price Today?
The Tibet Pharmaceuticals Inc stock price today is 0.00000.
What Is the Stock Symbol for Tibet Pharmaceuticals Inc?
The stock symbol for Tibet Pharmaceuticals Inc is ""TBET.""
What Stock Exchange Does Tibet Pharmaceuticals Inc Trade On?
Tibet Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Tibet Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Tibet Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TBET quote. (ISIN: VGG886151023)
OTC Markets
Currency in USD
0.00000
0.00000(0.00%)
Closed·
Fair Value
An estimate of a Tibet Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00000
0.00000
52 wk Range
0.00000
0.00010
TBET Scorecard
Full Analysis
Stock generally trades with low price volatility
TBET is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Tibet Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.000000.00000
52 wk Range
0.000000.00010
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TBET Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Tibet Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Tibet Pharmaceuticals Inc Company Profile
Tibet Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines. The company, through its operational entity, Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (YSTP), develops products in China for promoting health in human respiratory, digestive, urinary, and reproductive systems. Its commercialized products include 25 Ingredients Mandrake Pill, which is used to regulate menses to treat endometritis, pelvic inflammations, and women’s anemia; 15 Ingredients Gentiana Pill to treat bronchitis, emphysema, asthma, and hoarseness; 28 Ingredients Pinang Pill for treating cold waist hip pain, pus hematuria, and testis swelling; 18 Ingredients Chebulic (Myrobalan) Frusemide Pill for the treatment of kidney problems, lumbar and kidney pain, frequent urination, turbid urine, diabetes, and spermatorrhea; and Pomegranate Nichirin Pill to treat indigestion, back and leg pain, frequent urination, foot edema, impotence, and nocturnal emission. The company also develops Xuezang Guben pill indicated for the treatment of neurasthenia, insomnia, frequent urination, nocturnal emission, and women’s menopausal symptoms; Shengke I that is in Phase III clinical testing for treating type II diabetes; Shengke II, which is in Phase II clinical testing for treating impotence and premature ejaculation, prostrate disease, and memory loss; Jiuzan pill that is in Phase II clinical testing for the treatment of chronic gastroenteritis and peptic ulcers; and Antai pill, a pre-clinical stage product for treating hepatitis B. In addition, it focuses to commercialize Wupeng Pill for treating echimococosis, pandora tingling disease, diphtheria, anthrax, yellow water disease, and leprosy. The company was formerly known as Shangri-La Tibetan Pharmaceuticals, Inc. and changed its name to Tibet Pharmaceuticals Inc. in July 2010. Tibet Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Wanchai, Hong Kong.
Compare TBET to Peers and Sector
Metrics to compare | TBET | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTBETPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −0.5x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 0.0x | 1.2x | 2.6x | |
Price / LTM Sales | 0.0x | 1.0x | 3.2x | |
Upside (Analyst Target) | 0.0% | 170.3% | 42.0% | |
Fair Value Upside | Unlock | 19.9% | 6.6% | Unlock |
Earnings
Latest Release
Nov 14, 2011
EPS / Forecast
0.11 / --
Revenue / Forecast
8.58M / --
FAQ
What Stock Exchange Does Tibet Pharma Trade On?
Tibet Pharma is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Tibet Pharma?
The stock symbol for Tibet Pharma is "TBET."
What Is the Tibet Pharma Market Cap?
As of today, Tibet Pharma market cap is 14.00.
What Is Tibet Pharma's Earnings Per Share (TTM)?
The Tibet Pharma EPS (TTM) is 0.78.
From a Technical Analysis Perspective, Is TBET a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tibet Pharma Stock Split?
Tibet Pharma has split 0 times.
How Many Employees Does Tibet Pharma Have?
Tibet Pharma has 206 employees.
What is the current trading status of Tibet Pharma (TBET)?
As of 30 Jul 2025, Tibet Pharma (TBET) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.